Indoco Remedies (BOM:532612) Net Issuance of Preferred Stock : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Indoco Remedies's net issuance of preferred for the three months ended in Mar. 2025 was ₹0 Mil. The number is 0, which means that Indoco Remedies has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Indoco Remedies's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Indoco Remedies Net Issuance of Preferred Stock Historical Data

The historical data trend for Indoco Remedies's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies Net Issuance of Preferred Stock Chart

Indoco Remedies Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Indoco Remedies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Indoco Remedies Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Indoco Remedies Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoco Remedies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » Net Issuance of Preferred Stock

Traded in Other Exchanges

INDOCO:India

Address

166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098

Website

https://www.indoco.com

Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines